ACTRN12613000249752
Completed
Phase 4
The Use of Intravitreal Injection of Triamcinolone Acetonide in Diabetic Patients to Reduce Diabetic Macular Edema
suez canal university hospital0 sites19 target enrollmentMarch 4, 2013
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Diabetic macular edema
- Sponsor
- suez canal university hospital
- Enrollment
- 19
- Status
- Completed
- Last Updated
- 6 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •The major eligibility criteria for the study eyes included the following: (1\) best\-corrected visual acuity letter score between 20/40 and 20/320; (2\) definite retinal thickening resulting from DME on clinical examination involving the center of the macula assessed to be the main cause of visual loss; (3\) retinal thickness measured with optical coherence tomography (OCT) of 250 micro m or more in the central subfield ;(4\) Grid laser treatment was done at least three months earlier.
Exclusion Criteria
- •Principal exclusion criteria included; (1\) prior treatment with intravitreal corticosteroids (at any time), peribulbar steroid injection within the prior 6 months, or pars plana vitrectomy (at any time); (2\) a history of glaucoma or steroid\-induced IOP elevation that required IOP\-lowering treatment; (3\) average intraocular pressure of 23 mm Hg or more after three preinjection evaluations; (4\) eyes with ischemic maculopathy and (5\) patients with foveal traction detected with OCT.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Intravitreal Injection of Triamcinolone Acetonide in RetinitisIRCT201104266293N1Tehran University of Medical Sciences161
Completed
Phase 2
Intravitreal Triamcinolone for Clinically Significant Diabetic Macular Oedema that Persists after Laser Treatment (TDMO)Diabetic Macular OedemaMetabolic and Endocrine - DiabetesEye - Diseases / disorders of the eyeACTRN12605000211662Professor Mark Gillies70
Completed
Not Applicable
Intravitreal Triamcinolone with Transpupillary Thermal Therapy (TTT) for Subfoveal Choroidal Neovascularization in Age Related Macular DegeneratioAge-Related Macular Degeneration (ARMD) not available for current therapiesEye DiseasesAge-Related Macular Degeneration (ARMD)ISRCTN74123635Association to Avoid Blindness (Asociación Para Evitar La Ceguera) (APEC) (Mexico)200
Active, not recruiting
Not Applicable
Triamcinolone Acetonide Intravitreal Injection for the treatment for exudative maculopathy - NDexudative maculopathyMedDRA version: 8.1Level: LLTClassification code 10038862Term: Retinal exudatesEUCTR2006-001727-19-ITAZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI
Completed
Not Applicable
Effect of intravitreal triamcinolone injection combined with vitrectomy for proliferative diabetic retinopathy.Diabetic retinopathyJPRN-UMIN000020376Department of Ophthalmology, Faculty of Medical Science, University of Fukui60